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The contribution of the cell-bound hemolysin of Serratia marcescens to uropathogenicity 
was studied in an experimental urinary tract infection in rats. The strain carrying the Serratia 
hemolysin colonized the urinary tract more and Iead to a strenger inflammatory response 
compared to the isogenic hemolysin negative strain. 
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lntroduction 
Serratia marcescens is an important pathogen causing predominantly nosocomial 
infections in immunocompromised patients ranging from urinary tract infections to 
endocarditis, meningitis and bacteremia. Pathogenicity of this microorganism has been 
associated with a formation of fimbriae,1•2 the production of proteases, which degrade 
various serum proteins,1•3.4 the presence of different cell wall antigens5 and the ability 
to resist the bactericidal action of serum.6 Recently Braun et a/.7 noticed that Serratia 
marcescens strains rapidly lyse human erythrocytes in solution. On blood agar Serratia 
colanies show a narrow zone of a faint hemolysis. The Serratia hemolysin has been 
shown to differ markedly from the weil characterized E. coli hemolysin.8 lt is 
predominantly cell associated, requires actively metabolising bacteria and does not 
need calcium ions for activity. The hemolysin determinant is contained on a 7.5 kb 
fragment of chromosomal DNA and shows two open reading frames designated sh/A 
which encodes the hemolysin protein and sh/8 which somehow activates sh/A.9 Since 
there has been no study on the role of the Serratia hemolysin in experimental 
infections, we investigated the contribution of this hemolysin to uropathogenicity in an 
experimental rat model.10 
0882-401 0/89/080153+04 $03.00/0 © 1989 Academic Press limited 
154 R. Marre et al. 
Results and discussion 
As demonstrated in Fig. 1 renal colonization of the strain producing the Serratia 
hemolysin was more than five times higher than that of the Shl-negative recipient 
strain (P < 0.05). Bladder colonizaton was distinctly higher than renal colonization in 
both groups of rats with a tendency to higher colony counts in the group infected 
with 536/21 pES2. The mean bladder weights of animals infected with 536/21 pES2 
were more than double as high as in the control group (0.30 vs 0.14 g). Numbers of 
leukocytes in the urine were 2.6 times higher in the animals colonized with E. coli 
536/21 pES2. 
lt is obvious from the data presented here that the Serratia hemolysin contributes to 
uropathogenicity in an experimental rat pyelonephritis model. Shl-positive bacteria 
Iead to higher renal colonization than their non-hemolytic counterparts. Bladder 
colonization was also affected by the Serratia hemolysin but to a lesser extent. The 
contribution of Shl to inflammatory responses was indicated by an increase of 
leukocyturia and thickening of the bladder walls. These results are in line with those 
of König et a/.11 who were able to demonstrate that Shl induces the release of 
leukotriene from polymorphonuclear leukocytes, the release of histamine from rat mast 
cells, and chemiluminescence of neutrophils. 
The extent of contribution of Shl to uropathogenicity was similar to that of the 
secreted E. coli alpha hemolysin derived from an E. coli 018 strain.10 lt shows that a 
hemolysin which is predominantly cell bound and rapidly inactivated in non-growing 
bacteria, also exerts biological effects. The hemolysin might facilitate the destruction 
of the epithelium of the urinary tract and the tubuli and thus facilitate invasion of 
urinary tract tissue. 
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Fig. 1. Bacterial colonization of kidney and bladder by E. coli strain 536/21 (number of rats 36) and the 
transformant 536/21 pES2 {number of rats 40}. which carried the determinant of the Serratia hemolysin. 
Each column gives the mean value of cfu/g of tissue. Bars indicate the standard error. Leukocyturia {number 
of rats per strain::: 5) was calculated as number of cells eliminated per inin (median+standard error}. Each 
column represents the median of leukocytes eliminated per min, the bars indicate the standard error. 
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In this study the role of Serratia hemolysin in infection was demonstrated after 
transformation of a Shl·coding plasmid into an E. coli carrier strain which is weil 
adapted to the animal system used. Studies are underway to demonstrate whether or 
not the Serratia hemolysin also plays a roJe in the virulence of its natural host bacteria. 
Materialsand methods 
Strains. Since it was at first easier to construct isogenic pairs of E. coli than of Serratia which 
only differed in hemolytic activity, the well·characterized E. coli strain 536/21 06 K15 was used 
as a carrier strain for the recombinant Serratia hemolysin. This strain was previously used in 
this model of infection for studies on uropathogenicity and was able to colonize the rat urinary 
tract. The strain has been described in detail.10 Strain 536/21 was transformed with plasmid 
pES2, which carried the cloned chromosomal hemolysin determinant of Serratia marcescens.8 
The transformant showed a narrow zone of faint hemolysis on sheep blood agar similar to that 
of Seratia marcescens. With respect to other possible virulence factors such as serum resistance, 
fimbriae, cell wall antigens and growth rates strain 536/21 and transformant 536/21 pES2 were 
identical. 
Methods. For initiation of a urinary tract infection 1.5 ml of a suspension of the bacteria to 
be tested (concentration 107 cfu/ml) was injected via urethra into the bladder of the rats (strain: 
Han WIST) .10 This resulted in a vesicoureteral reflux and subsequent colonization of the kidneys. 
Depending on the virulence of the strains used, a persisting pyelonephritis might develop. One 
week after the infection the rats were sacrificed, kidneys and bladder removed aseptically, the 
bladders were opened and rinsed in sterile saline. Both organs were homogenized, appropriately 
diluted and viable counts were made on McConkey agar. The identity of the isolated colanies 
with the E. coli strains injected was tested serologically and by the presence of the chromosomally 
encoded Streptomycin resistance. The majority of the reisolated bacteria still contained the 
plasmid with the hemolysin gene. The mean number of cfu/g of tissue of each group was 
calculated and served as a measure of uropathogenicity. Forty rats were used in each group. ln 
order to evaluate leukocyturia, five rats of each group received 1 0 ml of 0.9% saline and 
furosemide (1 0 mg/kg) intraperitoneally on the sixth day of infection. The rats were placed 
singly into metabolic cages for 2 h. The urine was collected and the number of leukocytes 
determined. The cell elimination per min was calculated. The statistical evaluationwas performed 
according to Kruskai-Wallis followed by the Nemenyi-test, if statistically significant differences 
(P <0.05) were found. 12 
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